Bertrand Tavitian

Inserm, Université Paris-Sud

Papers

3

Total Citations

137

H-Index

3

About

Bertrand Tavitian is a leading figure in molecular imaging, whose work has fundamentally advanced the use of positron emission tomography (PET) for neuroinflammation. His primary research focus is the development of novel radiotracers targeting the translocator protein (TSPO, 18 kDa), a key biomarker of activated microglia in the brain. Tavitian’s major contribution lies in the radiosynthesis of several critical TSPO ligands, including [¹⁸F]DPA-714, [¹⁸F]PBR111, and [¹⁸F]PBR28. These compounds have become indispensable tools for visualizing neuroinflammatory processes in conditions such as Alzheimer’s disease, multiple sclerosis, and stroke, enabling researchers to track disease progression and evaluate therapeutic interventions in vivo. His seminal 2008 paper on the radiosynthesis of [¹⁸F]DPA-714 has garnered 88 citations, underscoring its foundational impact. By engineering these high-affinity, selective radioligands and establishing automated, reproducible synthesis protocols, Tavitian has bridged the gap between radiochemistry and clinical application, empowering a global community of neuroscientists to probe the dynamic role of neuroinflammation in brain health and disease.

Research Focus

Key Achievements

3
H-Index
3
Papers
137
Total Citations
46
Avg Citations/Paper
🏆 Most Cited Paper
Radiosynthesis of [<sup>18</sup>F]DPA‐714, a selective radioligand for imaging the translocator protein (18 kDa) with PET
88 citations · 2008
📈 Most Prolific Year: 2008 (2 Papers)
🤝 Key Collaborators: 18
🏛 Institutions: Inserm, Université Paris-Sud

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago